Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM027711-000
Application #
3610222
Study Section
Project Start
1991-12-15
Project End
1994-11-14
Budget Start
1991-12-15
Budget End
1992-06-14
Support Year
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Egorin, M J; Yuan, Z M; Sentz, D L et al. (1999) Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats. Cancer Chemother Pharmacol 43:445-53
Egorin, M J; Rosen, D M; Benjamin, S E et al. (1997) In vitro metabolism by mouse and human liver preparations of halomon, an antitumor halogenated monoterpene. Cancer Chemother Pharmacol 41:9-14
Egorin, M J; Sentz, D L; Rosen, D M et al. (1996) Plasma pharmacokinetics, bioavailability, and tissue distribution in CD2F1 mice of halomon, an antitumor halogenated monoterpene isolated from the red algae Portieria hornemannii. Cancer Chemother Pharmacol 39:51-60
Eiseman, J L; Yuan, Z M; Eddington, N D et al. (1996) Plasma pharmacokinetics and urinary excretion of the polyamine analogue 1, 19-bis(ethylamino)-5, 10, 15-triazanonadecane in CD2F1 mice. Cancer Chemother Pharmacol 38:13-20
Eiseman, J L; Eddington, N D; Leslie, J et al. (1994) Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice. Cancer Chemother Pharmacol 34:465-71
Leslie, J; Kujawa, J M; Eddington, N et al. (1993) Stability problems with taxol in mouse plasma during analysis by liquid chromatography. J Pharm Biomed Anal 11:1349-52